Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for this market. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
This report analyzes the US Market for Intranasal Drug Delivery in US$ Million by the following Therapeutic Areas:
- Allergic Infections
- Analgesics
- Osteoporosis
- Vaccinations
The report profiles 64 companies including many key and niche players such as:
Key Topics Covered:
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
SOURCE Research and Markets
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
